Many comments have been made along the lines of "why deny patients a treatment for a terrible disease that might provide some relief" . I thnk it was agent88, on another thread, who questioned how I, as a doctor, could justify such an attitude.
No-one would want to deny anyone with the disease an effective cure, but there are a couple of snags that go along with following that process to it's logical conclusion i.e. letting loose on patients any treatment that "might" be effective.
1 - unexpected and devastating side effects
2 - exploitation of the vulnerable who will clutch at straws out of desperation and be exposed to charlatans who take advantage of the situation to line their pockets.
Please note that these are general considerations and in the circumstances surrounding cVac it is exceedingly unlikely that they would be relevant.
However any relaxation of a high standard of medical research and introduction of treatments is fraught with danger. The loss of an effective treatment to some patients must be weighed against the potential harm to others.
In the case of cVac the safety data available to date lends substantial reassurance about making the treatment more generally available. This must be accompanied by detailed monitoring and auditing of outcomes and side effects.
- Forums
- ASX - By Stock
- IMM
- reply from martin rogers re dubai release
reply from martin rogers re dubai release, page-27
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
29.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $421.8M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 567 | 32.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
29.0¢ | 25 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 30000 | 0.285 |
3 | 83571 | 0.280 |
6 | 230290 | 0.275 |
8 | 749248 | 0.270 |
4 | 121547 | 0.265 |
Price($) | Vol. | No. |
---|---|---|
0.295 | 65000 | 2 |
0.300 | 193470 | 5 |
0.305 | 180000 | 2 |
0.310 | 141725 | 4 |
0.315 | 120000 | 2 |
Last trade - 09.13am 11/11/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
Day chart unavailable
The Watchlist
3DA
AMAERO INTERNATIONAL LTD
Hank Holland, Executive Chairman and CEO
Hank Holland
Executive Chairman and CEO
SPONSORED BY The Market Online